PRA bolsters late phase services

pharmafile | June 23, 2010 | Appointment | Research and Development |  CRO, PRA, appointment, research and development 

Contract research organisation PRA International has appointed Hani Zaki senior VP of its Late Phase Services business.

Late Phase Services (LPS) focuses on post-approval activities, an area of recent growth for the company under the leadership of Maria Harrison, PRA’s VP of LPS.

Steve Powell, senior VP of clinical informatics and LPS at PRA, said: “Hani joins PRA at a time of significant growth in LPS. Today’s post-approval market is offering more opportunities than ever due to global trends for mandated studies and expansion of registries and risk mitigation strategies required by regulators worldwide.

Advertisement

“We believe the combination of Maria’s operational and scientific knowledge and Hani’s focused post-approval business acumen will provide our customers with a world-class, global team.”

Zaki has more than 25 years of industry experience in both operational and business development management in the pharma and CRO industries.

He most recently served as corporate vice president and general manager for another major CRO’s post-approval division.

His pharma experience includes leading US clinical anti-infective operations for Rhone-Poulenc Rorer (now Sanofi Aventis).

Related Content

Lilly secures conditional MHRA approval for new blood cancer treatment

Crown Bioscience opens new US model development centre

Crown Bioscience, a US global contract research organisation (CRO) that is part of JSR Life …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy

Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

The Gateway to Local Adoption Series

Latest content